Michael Distler

🚀 Insights in Medical 3D Printing at the Point of Care! New Edition of the #3DADEPTMag ... (Interview with Florian M. Thieringer) The Swiss MAM Research Group at the Department of Biomedical Engineering | University of Basel / University of Basel and the 3D (Print) Lab at the University Hospital Basel are harnessing 3D printing technologies to enhance complex surgeries (not only) in the cranio-maxillofacial field. 🌟 By utilizing patient-specific implants and surgical aids produced through 3D printing, they achieve more precise and efficient operations, leading to better patient outcomes. This technology allows for surgical procedures to be meticulously planned and tailored solutions to be created right in the operating room. 🏥💡 Looking ahead, these innovations improve treatment methods and pave the way for personalized medical solutions. 🌍🔬 ACCESS the digital mag 👉 : https://lnkd.in/eBMK_E5h #Medicine #Switzerland #3DPrinting #Innovation #Healthcare #PointofCare #PatientCare #Surgery #DigitalTransformation #UniversityOfBasel #TeamUSB #SwissMAM #DBE

94

4 Kommentare

The two-day closing symposium at Universitäres Herz- und Gefäßzentrum Hamburg, Universitätsklinikum Hamburg Eppendorf for the INCREASE study was a resounding success. The symposium featured a comprehensive discussion of key aspects of ERAS and strategies for enhancing perioperative patient care. The session was highlighted by a keynote address Prof. Henrik Kehlet from Copenhagen, one of the most experienced ERAS spokesmen in Europe, delivering an inspiring presentation. INCREASE (INterdisziplinäre und sektorenübergreifende Versorgung in der HerzChiRurgiE am Beispiel von minimal-invASiven HErzklappeneingriffen) is a prospective, randomized-controlled, bicentric study that compares the ERAS model with standard therapy in the setting of minimally-invasive surgery at Universitätsklinikum Hamburg Eppendorf and Universitätsklinikum Augsburg under the supervision of Prof. Dr. Evaldas Girdauskas. This is study analyses the potential benefits of the ERAS approach for patient care. ⏳ Please stay tuned for the results of the study during the course of the year. ⌛ Prof. Dr. Susanne Klotz Sina Stock Thilo Welsch

48

2 Kommentare

Our new article in German in "Monitor Versorgungsforschung". The goal of this study was to investigate the prevalence of and the factors associated with the in-hospital mortality of patients hospitalized with heart failure (HF). This multicenter cross-sectional study was based on data of 19,288 HF cases from fourteen hospitals across Germany. The mortality rate was 9.7% and increased from 4.2% in the age group ≤65 years to 15.1% in the age group >90 years. Left ventricular failure with symptoms at rest, acute renal failure, respiratory failure, pneumonia, and pleural effusion were associated with a higher mortality risk. While our study provides a comprehensive snapshot of in-hospital mortality in HF patients, it also highlights the need for ongoing research to deepen our understanding of the intricate interplay between various risk factors. IQVIA Germany Oliver Laduch #hospital #heartfailure #mortality

27

🔬📚 New Insights in Obstetrics and Gynecology Training 📚🔬 Exciting developments in medical education! A recent study has illuminated the gap between the clinical importance of ultrasound (US) and the adequacy of postgraduate training in obstetrics and gynecology. This research underscores a critical need for standardized training frameworks. Key Findings: Self-Learning Reliance: A significant reliance on self-learning among residents. Need for Structured Supervision: Urgency for structured supervision and mentorship. Barriers in Hospital Operations: Identified barriers that hinder comprehensive US training. Advocacy for Organizational Reforms: Calls for reforms to support structured education. 🌍 Global Relevance: This study holds significant international importance, offering insights that transcend national boundaries and highlight a universal challenge within the medical education sector. 📈 Recommendations: The research advocates for standardized training frameworks and comprehensive educational reforms. A proposed model could be adapted and implemented across various healthcare systems globally, aligning postgraduate education with clinical demands to improve patient care. 🤝 Future Implications: The findings could inspire similar studies and innovations worldwide, fostering international collaboration and exchange of best practices in ultrasound education. 🩺 Ultimate Goal: Emphasizing the need for proficient and confident specialists in obstetrics and gynecology, this study aims to contribute to enhanced diagnostics, treatment, and healthcare outcomes globally. Let's work together to bridge the gap in postgraduate training and elevate the standards of medical education! 🌟 https://lnkd.in/eRShyGqZ #MedicalEducation #ObstetricsAndGynecology #UltrasoundTraining #HealthcareReform #GlobalHealth #ClinicalTraining #Mentorship #InternationalCollaboration #MedicalResearch #ResidentEducation #HealthcareInnovation #TrainingStandards #MedicalMentorship #PatientCare #HospitalOperations Agnes Franziska Wittek #HealthcareEducation #GlobalMedicine #MedicalExcellence #FutureOfHealthcare

12

🤩 I'm excited that #TeamElli has been part of the pilot phase of the German Cardiac Arrest Registry (G-CAR), a national, prospective, multicentre registry aimed at improving our understanding and management of out-of-hospital cardiac arrest (OHCA) patients in Germany. 🌍 In Europe, over 300,000 individuals experience OHCA annually, yet survival with good neurological outcomes remains limited. During the 16-month pilot phase, 15 centres enrolled 559 consecutive patients aged ≥18 years. 🗒 Key findings include a median age of 66 years, layperson resuscitation in 60.5% of cases, and shockable initial rhythms in 46.4%. Notably, 62.9% underwent coronary angiography and 61.4% received PCI. Despite advancements, the in-hospital mortality rate was 70.5%, primarily due to anoxic brain damage. eCPR was performed in 11.0% of patients, with an in-hospital mortality rate of 85.2%. 🎯 G-CAR focuses on cardiac and interventional treatment, and these initial results highlight the need for further analysis and expansion to a national scale. This initiative holds promise for enhancing patient outcomes and providing valuable data for future research. 🙏 THX PD Dr. med. Janine Pöss, FESC and Christoph Sinning for giving us the opportunity to be part of this forward-looking project #Cardiology #EmergencyMedicine #OHCA #ClinicalResearch #GCAR #Resuscitation https://rdcu.be/dKUFA

43

2 Kommentare

"𝗘𝘅𝗽𝗲𝗿𝘁𝘀 𝗮𝗿𝗲 𝗼𝗽𝘁𝗶𝗺𝗶𝘀𝘁𝗶𝗰: 𝗿𝗲𝗶𝗺𝗯𝘂𝗿𝘀𝗲𝗺𝗲𝗻𝘁 𝗳𝗼𝗿 𝗔𝗜 𝗶𝗻 𝗺𝗲𝗱𝗶𝗰𝗶𝗻𝗲 𝘄𝗶𝗹𝗹 𝗰𝗼𝗺𝗲" Medical imaging and informatics experts are confident that if AI is implemented across the board in medicine, reimbursement will automatically follow. They draw parallels with the historical introduction of PACS software and argue that AI is likely to follow a similar path. Despite the lack of current reimbursement, stakeholders should adopt AI and explore how AI can improve everyday clinical practice without getting too caught up in ROI calculations. In the end, however, the cash register has to be right - we all know that. Dear medical colleagues, what do you think?  Is the widespread use of AI initially without reimbursement realistic or unrealistic? What joint steps are necessary to establish AI in clinical routine and at the same time drive forward reimbursement? Full article: https://lnkd.in/eCxySdak

13

5 Kommentare

Congrats: Another great report from our #IBD team www.gastric.de and #Neuro_MA #unimedizinma #UniHeidelberg #ResearchLifesci Linking disturbed #brain-#gut-interactions to #fatigue #depression #Crohn’s disease #uniklinikma #mannheim #neurology #gastroenterology #colitis https://t.co/FYQ2vFw644

10

1 Kommentar

I am honoured to have been appointed a member of the Charité - Universitätsmedizin Berlin Research Committee. Research is the key for improving the care for our patients. Particularly, I am fascinated by the interdisciplinary field of digitalisation, which will have a significant impact on the future of medicine.  I am looking forward to my new role - in close dialogue with my colleagues and research partners like Ulrich Stöckle, Carsten Perka, Univ.-Prof. Dr. Ing. Georg Duda, Felix Balzer, Doruk Akgun, Robert Zahn, PD Dr. med. Vera Jaecker, MHBA, Sebastian Meller, Tobias Winkler, Tobias Gehlen, Stefanie Donner, Andrej Trampuz, Priv.-Doz. Dr. med. Serafim Tsitsilonis, MSc, PhD, Rony-Orijit Dey Hazra, PD Dr. Akira-Sebastian Poncette, Heiko Tzschätzsch, Mark Heyland, PD Dr. med. Timo Auer, Sebastian Hölzl, Dr. med. Niklas Tuttle, Dr. med. Dominik Adl Amini, Alaa Bejaoui, Julian Zierke, Denis Zainullin and many other national and also international fellow researchers! #Charité, #research, #future, #orthopaedics, #traumatology, #digitalisation, #OTdigital, #REPAIR, #team, #interdisciplinary, #international, #DGOU, #AGDigitalisation

62

4 Kommentare

🌟 Exciting updates from the European Society for Radiotherapy and Oncology (ESTRO) congress in Glasgow! 🎉 Today, Leila E. presented a proffered paper on a study from Institut Godinot: 🔬 This retrospective analysis showcases High-Dose Rate (HDR) interstitial brachytherapy (iBT) as a potent alternative to surgery for treating primary nasal basal cell carcinoma (BCC) and cutaneous squamous cell carcinoma (cSCC). With a 90% complete response rate observed in 10 patients (80% male, median age 69), and treatments ranging from 40 Gy to 45 Gy across 9-10 fractions, HDR iBT demonstrates significant efficacy and minimal aesthetic impact. 🎯 🙌 Bravo to Leila E. and the entire team for the excellent work ! Proud to be part of this innovative team. Special thanks to António Da Silva Ribeiro Mota, the supervisor of the study. Here’s to further advancing our understanding and treatment methods in nasal carcinoma! 💪 #ESTRO #Oncology #RadiationTherapy #SkinCancer #MedicalInnovation

42

Nuclear Medicine contributes significantly to the Diagnosis and Treatment of Prostate Cancer

6

Radiation Therapy for Benign Diseases: Insights from my visit with Dr. M. Heinrich Seegenschmiedt During my visit with Dr. Seegenschmiedt, a renowned radiation oncologist in Dusseldorf, Germany, I gained valuable insights into the use of radiation therapy for the treatment of benign diseases. Here are the key takeaways: ❇️Significant Patient Volume Dr. Seegenschmiedt delivers over 1,000 fractions of radiation therapy per month, translating to approximately 200-250 new or recurring patients receiving radiation therapy for the treatment of benign diseases. This is an incredibly high number and highlights the significant demand and acceptance of this treatment modality in Germany. This is done with orthovoltage Xstrahl machine. ❇️Impressive Treatment Responses The patient treatment responses were remarkable, with the most common conditions being Dupuytren's contracture, Ledderhose disease, osteoarthritis, tendinopathies, bursitis, and plantar fasciitis. Dr. Seegenschmiedt's experience demonstrates the efficacy of radiation therapy in managing a wide range of benign musculoskeletal conditions. ❇️Need for Specialized Training It became evident that radiation oncologists require specialized training in the management of benign diseases. Current residency programs do not adequately prepare physicians for this treatment approach. Appropriate diagnosis through physical examination and imaging, determination of suitable treatment fields, and understanding contraindications require significant knowledge and expertise. ❇️Enormous Potential The need and potential for radiation therapy in the management of painful musculoskeletal conditions are enormous. With the aging population and the increasing prevalence of these conditions, radiation therapy could offer an effective and non-invasive treatment option for many patients. ❇️Collaboration and Education In Germany, there is a well-established collaboration between radiation oncologists and orthopedic surgeons, as well as other referring physicians. However, in the USA and other countries, there is a need to better educate and collaborate with colleagues in other specialties to raise awareness and promote the use of radiation therapy for benign diseases when appropriate. Overall, Dr. Seegenschmiedt's experience and insights highlight the significant potential of radiation therapy in the management of benign diseases, particularly in the field of musculoskeletal conditions. However, specialized training, collaboration, and education are crucial to ensure the safe and effective implementation of this treatment approach.

100

6 Kommentare

EuroAnaesthesia 2024 in Munich is fast approaching. We would like to remind you that the PROVE Network—Research Group Business Meeting will be held on Sunday, May 26, 2024, from 10:00 AM to 12:00 PM in Room Königsee. The room is equipped for hybrid meetings. Please use the following link to join the meeting in case you are not in Munich (ZOOM) https://lnkd.in/dtFNMGdX: with Meeting ID 849 1437 8534 and Passcode 0.1+%90= (note: this link remains the same for the entire duration of the congress. Please ensure you connect at the correct time to attend your respective meetings.) Thank you, and we look forward to seeing you in Munich. Marcus Schultz, Marcelo Gama de Abreu, Ary Serpa Neto MD MSc PhD FCICM, Sabrine Hemmes, Denise Battaglini, Chiara Robba, Lorenzo Ball, David van Meenen, Robert Huhle, Laura Buiteman-Kruizinga, Martin Scharffenberg, Jakob Wittenstein, Frederique Paulus, Prashant Nasa #PRotectiveVEntilationNetwork #PROVE #ESAIC #Euroanaesthesia #IntensiveCare #Anesthesia #ventilation #ICU #IntraOperativeVentilation #RCT #ObservationalStudies #Delphi #PoooledDatabases

26

1 Kommentar

Despite exciting new treatments like biological DMARDs, we still can't predict therapy response with our current set of biomarkers. As a consequence, treatments are picked through trial and error. In this recent interview, I highlighted new advancements in experimental rheumatology. One possibility I discussed is to classify diseases based on their synovial pathotype to ensure a more accurate prognosis, especially in the case of #rheumatoidarthritis patients. Check it out below (in German) 👇

16

I am glad to share our latest publication in the Eur Journal of Radiology! Our systematic review, "Prognostic role of cardiovascular magnetic resonance in Takotsubo syndrome," explores the potential of CMR to provide prognostic insights for patients with Takotsubo syndrome (TS). Despite its established role in TS diagnosis and management, the prognostic value of CMR remains unclear. Our review of five studies involving 564 patients highlights correlations between CMR parameters and major adverse cardiovascular and cerebrovascular events. These findings suggest the potential clinical utility of CMR in TS, though further research is needed. Special thanks to Riccardo Cau! https://lnkd.in/dfndaReF #Cardiology #Radiology #CMR #TakotsuboSyndrome #MedicalResearch #HealthcareInnovation

40

5 Kommentare

Funny way to illustrate distribution of unspecific bone uptakes (UBU) in PSMA imaging in this new paper 🤪 👏 https://lnkd.in/dBk-7-Z6

383

9 Kommentare

🚨12 Painful Musculoskeletal Conditions That Can Be Treated Effectively with Low Dose Radiation Therapy🚨 As I visit Dr. M. Heinrich Seegenschmiedt in Germany this week, I’m amazed at all of the various conditions treated with radiation therapy. Low Dose Radiation Therapy (LDRT) is proving to be an effective treatment for a wide range of painful musculoskeletal conditions. Here are some of the conditions that can benefit from LDRT: 1. Osteoarthritis (activated or degenerative) 2. Heel spur (plantar fasciitis) 3. Calcific tendinitis (calcified shoulder) 4. Tendinitis and tendon inflammations 5. Bursitis 6. Tennis/golfer's elbow (epicondylitis) 7. Hand/finger osteoarthritis (rhizarthrosis, Heberden's nodes, Bouchard's nodes) 8. Jumper's knee (patellar tendinitis) 9. Tenosynovitis (inflammation of tendon sheaths) 10. Frozen shoulder (adhesive capsulitis) 11. Shoulder impingement syndrome 12. Inflammatory osteoarthritis of the shoulder joint The potential of LDRT to alleviate pain and improve mobility in these conditions is truly remarkable. Looking forward to learning more and sharing insights from this visit!

117

9 Kommentare

Learning

1